KDSR (3-ketodihydrosphingosine reductase; also known as FVT-1 and SDR35C1) is an NADPH-dependent short-chain dehydrogenase/reductase that catalyses the second step of de novo sphingolipid biosynthesis, the reduction of 3-ketodihydrosphingosine (3-ketosphinganine / 3-oxosphinganine) to dihydrosphingosine (sphinganine). This step follows the serine palmitoyltransferase (SPT)-catalysed condensation of L-serine and palmitoyl-CoA and precedes N-acylation by the ceramide synthases, feeding the downstream production of ceramide and complex sphingolipids. It is the principal KDS reductase in mammalian cells and is essential for flux through this pathway. The enzyme is a multi-pass endoplasmic reticulum membrane protein whose large catalytic domain, carrying the NADPH-binding site and active-site residues, faces the cytosolic side of the ER membrane. Loss-of-function mutations cause erythrokeratodermia variabilis et progressiva 4 (a recessive skin/keratinization disorder) and a spectrum of keratinization disorders that can be accompanied by thrombocytopenia due to impaired proplatelet formation.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005789
endoplasmic reticulum membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference that KDSR is active in the ER membrane. This is strongly supported by direct experimental evidence in human and mouse.
Reason: KDSR is an integral ER membrane protein with its catalytic domain on the cytosolic face of the ER; the IBA localization is correct and at an appropriate level of specificity.
Supporting Evidence:
PMID:15328338
hFVT-1 is localized at the endoplasmic reticulum
file:human/KDSR/KDSR-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0030148
sphingolipid biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference that KDSR is involved in sphingolipid biosynthesis. This is the core biological process of the gene.
Reason: KDSR catalyses the second, obligatory step of de novo sphingolipid biosynthesis; this is directly supported by experimental and mutation data in addition to the phylogenetic inference.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
the second step of de novo sphingolipid biosynthesis
PMID:19141869
FVT1 is the principal 3-ketosphinganine reductase in mammalian cells
|
|
GO:0006666
3-keto-sphinganine metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference that KDSR participates in 3-keto-sphinganine metabolism. KDSR consumes 3-keto-sphinganine (3-ketodihydrosphingosine), its direct substrate.
Reason: 3-keto-sphinganine (3-oxosphinganine) is the direct substrate of KDSR; this is a precise, correct BP for the enzyme's substrate metabolism, complementing the broader sphingolipid biosynthetic process term.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH + H(+)
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference of 3-dehydrosphinganine reductase (KDS reductase) activity. This is the defining molecular function of KDSR.
Reason: This IBA annotation captures the core molecular function of KDSR and is concordant with direct enzymatic characterization of the purified human protein.
Supporting Evidence:
PMID:15328338
exhibited NADPH-dependent KDS reductase activity
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic annotation of ER membrane localization from the UniProt Subcellular Location mapping, consistent with experimental evidence.
Reason: The ER membrane localization is experimentally established; this IEA is accurate.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0006666
3-keto-sphinganine metabolic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro2GO electronic annotation to 3-keto-sphinganine metabolic process based on the KDSR-like family signature (IPR045022).
Reason: The InterPro family assignment correctly maps to the substrate-metabolism BP; consistent with the enzyme's characterized reaction.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH + H(+)
|
|
GO:0030148
sphingolipid biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (combined IEA methods / ARBA) to sphingolipid biosynthetic process, the core BP of KDSR.
Reason: Correct core biological process, redundant with better-supported experimental annotations to the same term.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
the second step of de novo sphingolipid biosynthesis
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation of the reductase molecular function from InterPro/RHEA/EC mappings (EC 1.1.1.102, RHEA:22640).
Reason: Correctly assigns the defining molecular function via the enzyme's EC number and Rhea reaction; concordant with experimental data.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
EC=1.1.1.102
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" from a large-scale yeast two-hybrid interactome study, capturing interactions with KIF1B, HSPB1, TTR and WFS1. This term is uninformative about KDSR's molecular function.
Reason: The GO:0005515 "protein binding" term conveys no specific functional information, and the underlying interactions are high-throughput Y2H hits from a neurodegeneration interactome screen with no established relevance to KDSR's enzymatic role. Per curation guidance, bare protein binding is retained but flagged as an over-annotation rather than removed.
Supporting Evidence:
PMID:32814053
systematic yeast two-hybrid interaction screening
|
|
GO:0030148
sphingolipid biosynthetic process
|
TAS
Reactome:R-HSA-1660661 |
ACCEPT |
Summary: Reactome traceable annotation placing KDSR in de novo sphingolipid biosynthesis.
Reason: Reactome correctly assigns KDSR to the sphingolipid de novo biosynthesis pathway; this is the core BP.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
the second step of de novo sphingolipid biosynthesis
|
|
GO:0006665
sphingolipid metabolic process
|
IEA
GO_REF:0000041 |
KEEP AS NON CORE |
Summary: UniPathway-based electronic annotation to the broad sphingolipid metabolic process term.
Reason: Correct but less informative than the biosynthetic-process child term (GO:0030148), which is separately annotated with experimental support. Retained as a valid but general parent annotation.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
PATHWAY: Lipid metabolism; sphingolipid metabolism
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
TAS
Reactome:R-HSA-428123 |
ACCEPT |
Summary: Reactome traceable annotation of the KDS reductase molecular function (reaction "KDSR reduces 3-ketosphingoid").
Reason: Correctly captures the defining molecular function of KDSR.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH + H(+)
|
|
GO:0046513
ceramide biosynthetic process
|
IDA
PMID:1317856 Subcellular localization and membrane topology of serine pal... |
KEEP AS NON CORE |
Summary: Classic biochemical study localizing serine palmitoyltransferase, 3-dehydrosphinganine reductase and sphinganine N-acyltransferase to the cytosolic face of mouse liver ER. The reductase activity feeds the pathway that produces dihydroceramide/ceramide.
Reason: KDSR (3-dehydrosphinganine reductase) provides sphinganine, an obligatory precursor for ceramide synthesis, and this paper measures the reductase activity as part of the early ceramide-forming pathway. However, KDSR does not itself catalyse ceramide formation, so ceramide biosynthetic process is a pathway-level annotation kept as non-core rather than a direct catalytic function.
Supporting Evidence:
PMID:1317856
are responsible for the first steps in sphingolipid
PMID:1317856
3-oxosphinganine, sphinganine, and dihydroceramide
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
IDA
PMID:36170811 De novo sphingolipid biosynthesis necessitates detoxificatio... |
ACCEPT |
Summary: Study establishing that KDSR reduces 3KDS to sphinganine and that KDSR loss causes toxic 3KDS accumulation. Supports the reductase molecular function.
Reason: Directly attributes the 3KDS-reducing (3-dehydrosphinganine reductase) activity to KDSR; this is the core molecular function.
Supporting Evidence:
PMID:36170811
3KDS is subsequently converted to sphinganine by 3KDS reductase (KDSR)
|
|
GO:0006686
sphingomyelin biosynthetic process
|
IDA
PMID:36170811 De novo sphingolipid biosynthesis necessitates detoxificatio... |
MARK AS OVER ANNOTATED |
Summary: KDSR loss affects downstream sphingomyelin levels because sphingomyelin is a major downstream product of de novo sphingolipid biosynthesis; sphingomyelins were measured as downstream readouts of the KDSR-dependent pathway.
Reason: KDSR contributes to sphingomyelin biosynthesis only indirectly, by supplying the sphinganine backbone upstream; it does not catalyse any sphingomyelin-forming step. In this study cancer cells could still salvage sphingomyelin, and total sphingomyelins did not necessarily decrease on KDSR knockout. This is a distal pathway-product annotation rather than a direct function.
Supporting Evidence:
PMID:36170811
major downstream products of sphingolipid biosynthesis
|
|
GO:0006688
glycosphingolipid biosynthetic process
|
IDA
PMID:34080016 Glucosylceramide and galactosylceramide, small glycosphingol... |
MARK AS OVER ANNOTATED |
Summary: Reference is a review of glucosylceramide and galactosylceramide biology. Glycosphingolipids are distal products of the de novo pathway that KDSR feeds, but the reference does not itself assay or even mention KDSR.
Reason: Glycosphingolipid biosynthesis is several enzymatic steps downstream of KDSR (sphinganine -> ceramide -> glucosyl/galactosylceramide -> complex GSL); KDSR catalyses none of these glycosylation steps. The cited review never mentions KDSR, so this is a pathway-level over-annotation, not a direct function.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
the second step of de novo sphingolipid biosynthesis
|
|
GO:0046513
ceramide biosynthetic process
|
IDA
PMID:16120614 Serinc, an activity-regulated protein family, incorporates s... |
KEEP AS NON CORE |
Summary: Study of the Serinc protein family, which forms an intracellular complex with enzymes of serine and sphingolipid biosynthesis to incorporate serine into membrane lipids. The abstract does not directly assay KDSR in ceramide synthesis.
Reason: Ceramide biosynthesis is downstream of the sphinganine KDSR produces; KDSR is required for the pathway but does not catalyse a ceramide-forming step. Because only the abstract is available and the experimental (IDA) full text may implicate KDSR in the biosynthetic complex, the annotation is retained as a valid pathway-level, non-core assignment rather than removed.
Supporting Evidence:
PMID:16120614
enzymes involved in serine and sphingolipid biosyntheses
|
|
GO:0098554
cytoplasmic side of endoplasmic reticulum membrane
|
IDA
PMID:19416851 Identification of small subunits of mammalian serine palmito... |
ACCEPT |
Summary: Annotation that KDSR is active on the cytoplasmic side of the ER membrane. This is the most precise localization consistent with the enzyme's topology.
Reason: KDSR's large catalytic domain, bearing the active-site and NADPH-binding residues, faces the cytosol at the ER membrane; the cytoplasmic-side term is the most accurate CC and reflects where catalysis occurs.
Supporting Evidence:
PMID:15328338
which contains putative active site residues, faces the cytosol
file:human/KDSR/KDSR-uniprot.txt
TOPO_DOM 26..270
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:15328338 FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with... |
ACCEPT |
Summary: Direct experimental (immunofluorescence) demonstration that human FVT-1/KDSR localizes to the endoplasmic reticulum.
Reason: Robust experimental support for ER membrane localization.
Supporting Evidence:
PMID:15328338
hFVT-1 is localized at the endoplasmic reticulum
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:19141869 Tsc10p and FVT1: topologically distinct short-chain reductas... |
ACCEPT |
Summary: Experimental localization and topology study placing FVT1/KDSR at the ER membrane.
Reason: Confirms ER membrane localization by independent experimental methods.
Supporting Evidence:
PMID:19141869
oriented to place
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
EXP
PMID:15328338 FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with... |
ACCEPT |
Summary: Purified recombinant human FVT-1/KDSR exhibits NADPH-dependent KDS reductase activity in vitro, and rescues KDS reductase-deficient yeast.
Reason: Direct enzymatic demonstration of the defining molecular function; core function.
Supporting Evidence:
PMID:15328338
exhibited NADPH-dependent KDS reductase activity
|
|
GO:0006666
3-keto-sphinganine metabolic process
|
IMP
PMID:19141869 Tsc10p and FVT1: topologically distinct short-chain reductas... |
ACCEPT |
Summary: Silencing/mutation of FVT1 alters 3-ketosphinganine reductase activity, implicating KDSR in 3-keto-sphinganine metabolism.
Reason: Loss-of-function evidence supports KDSR's role in metabolizing its substrate 3-keto-sphinganine.
Supporting Evidence:
PMID:19141869
FVT1 is the principal 3-ketosphinganine reductase in mammalian cells
|
|
GO:0030148
sphingolipid biosynthetic process
|
IMP
PMID:19141869 Tsc10p and FVT1: topologically distinct short-chain reductas... |
ACCEPT |
Summary: Mutational/silencing evidence that FVT1/KDSR is required for long-chain base (sphingoid) synthesis, i.e. sphingolipid biosynthesis.
Reason: Core biological process supported by loss-of-function data.
Supporting Evidence:
PMID:19141869
required for long-chain base synthesis in yeast and mammals
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
IMP
PMID:19141869 Tsc10p and FVT1: topologically distinct short-chain reductas... |
ACCEPT |
Summary: FVT1 silencing directly correlates with cellular KDS reductase activity, identifying KDSR as the principal enzyme carrying this activity.
Reason: Loss-of-function evidence for the defining molecular function; core function.
Supporting Evidence:
PMID:19141869
a direct correlation between FVT1 levels and reductase activity
|
|
GO:0030148
sphingolipid biosynthetic process
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity-based transfer of sphingolipid biosynthetic process from the yeast ortholog (TSC10, P38342).
Reason: Correct core BP; the ortholog-based inference agrees with direct experimental data in human.
Supporting Evidence:
PMID:19141869
required for long-chain base synthesis in yeast and mammals
|
|
GO:0070402
NADPH binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity inference of NADPH binding, consistent with the Rossmann-fold NADPH-binding motif and the NADPH-dependent reductase mechanism.
Reason: KDSR is an NADPH-dependent reductase with a conserved N-terminal NADPH-binding (Rossmann) region; NADPH binding is a genuine molecular function supporting the catalytic activity.
Supporting Evidence:
PMID:15328338
exhibited NADPH-dependent KDS reductase activity
file:human/KDSR/KDSR-uniprot.txt
/ligand="NADPH"
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
IMP
PMID:28575652 Mutations in KDSR Cause Recessive Progressive Symmetric Eryt... |
ACCEPT |
Summary: Disease-gene study showing biallelic KDSR mutations cause progressive symmetric erythrokeratoderma, with yeast complementation and immunohistochemistry demonstrating defective KDSR function.
Reason: Patient mutations that abolish/impair the reductase function, validated by yeast complementation, provide loss-of-function support for the enzymatic activity.
Supporting Evidence:
PMID:28575652
demonstrated that the mutations cause defects in KDSR function
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
KEEP AS NON CORE |
Summary: High-throughput proteomics identification of KDSR in the membrane proteome of an NK-like cell line.
Reason: Correct but very general; KDSR is an integral membrane protein, and the more specific ER membrane / cytoplasmic side of ER membrane annotations are the informative localizations. Retained as a non-core, low-specificity localization.
Supporting Evidence:
PMID:19946888
define the composition of the membrane
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-428123 |
ACCEPT |
Summary: Reactome traceable annotation of ER membrane localization.
Reason: Consistent with the experimentally established ER membrane localization.
Supporting Evidence:
file:human/KDSR/KDSR-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0005783
endoplasmic reticulum
|
IDA
PMID:15364918 Lateral diffusion of inositol 1,4,5-trisphosphate receptor t... |
ACCEPT |
Summary: MGI-assigned IDA to endoplasmic reticulum. The cited reference (PMID:15364918) is a study of IP3R1 lateral diffusion in neurons and does not concern KDSR, so this appears to be a mis-attributed citation; however ER localization of KDSR is itself well established.
Reason: The endoplasmic reticulum localization is correct and independently supported by direct experimental evidence (PMID:15328338, PMID:19141869). The original reference appears to be a wrong-PMID citation (flagged in reference_review), but the annotation content is accurate and is retained on the basis of the other evidence.
Supporting Evidence:
PMID:15328338
hFVT-1 is localized at the endoplasmic reticulum
|
|
GO:0006666
3-keto-sphinganine metabolic process
|
IDA
PMID:15364918 Lateral diffusion of inositol 1,4,5-trisphosphate receptor t... |
ACCEPT |
Summary: MGI-assigned IDA linking KDSR to 3-keto-sphinganine metabolism. The cited reference is an IP3R1 diffusion study unrelated to KDSR, so the citation appears mis-attributed, but the underlying biology (KDSR metabolizes 3-keto-sphinganine) is correct.
Reason: KDSR reduces 3-keto-sphinganine (its substrate); the BP is correct and well supported by direct enzymology elsewhere. The original PMID is flagged as a likely wrong-identifier citation but does not affect the correctness of the annotation.
Supporting Evidence:
PMID:19141869
FVT1 is the principal 3-ketosphinganine reductase in mammalian cells
|
|
GO:0047560
3-dehydrosphinganine reductase activity
|
IDA
PMID:15364918 Lateral diffusion of inositol 1,4,5-trisphosphate receptor t... |
ACCEPT |
Summary: MGI-assigned IDA to the reductase molecular function. The cited reference is an IP3R1 lateral-diffusion study unrelated to KDSR, so the citation is likely mis-attributed; nonetheless the reductase activity is the well-established core function of KDSR.
Reason: The 3-dehydrosphinganine reductase activity is the defining, extensively validated molecular function of KDSR. The original PMID appears to be a wrong-identifier citation (flagged in reference_review), but the annotation itself is correct and supported by direct enzymology (PMID:15328338, PMID:19141869).
Supporting Evidence:
PMID:15328338
exhibited NADPH-dependent KDS reductase activity
|
|
GO:0005576
extracellular region
|
TAS
PMID:8417785 FVT-1, a novel human transcription unit affected by variant ... |
REMOVE |
Summary: Legacy annotation (ProtInc) derived from the 1993 FVT-1 cloning paper, which described FVT-1 as a "putatively secreted protein" based on sequence prediction before its function was known.
Reason: This localization is contradicted by all subsequent experimental evidence KDSR is a multi-pass integral endoplasmic reticulum membrane protein with its catalytic domain facing the cytosol, not a secreted/extracellular protein. The extracellular assignment reflects an outdated sequence-based prediction of secretion that has been superseded, and is a demonstrably wrong legacy inference.
Supporting Evidence:
PMID:8417785
codes for a putatively secreted protein of 36 Kd
file:human/KDSR/KDSR-uniprot.txt
Multi-pass
|
Gene: KDSR / FVT1 / SDR35C1, human. 332 aa, ER membrane, short-chain dehydrogenase/reductase (SDR) family.
KDSR catalyses the second step of de novo sphingolipid biosynthesis: the NADPH-dependent
reduction of 3-ketodihydrosphingosine (3-ketosphinganine / 3-oxosphinganine, "3KDS") to
dihydrosphingosine (sphinganine). This follows the SPT-catalysed condensation of L-serine +
palmitoyl-CoA and precedes N-acylation by the ceramide synthases (CERS).
- EC 1.1.1.102; RHEA:22640; the physiological direction is reduction (right-to-left in the UniProt
Rhea reaction sphinganine + NADP(+) = 3-oxosphinganine + NADPH + H(+)).
- The only KDS reductase in mammals; silencing directly reduces cellular reductase activity
PMID:19141869.
- Human FVT-1 rescues TSC10-null yeast and purified recombinant hFVT-1 has NADPH-dependent KDS
reductase activity in vitro PMID:15328338.
ER membrane, multi-pass; the large hydrophilic catalytic domain (with the active-site residues)
faces the cytosol [PMID:15328338; PMID:1317856]. UniProt: two C-terminal TM helices (271-291,
294-314), cytoplasmic catalytic domain 26-270. GO:0098554 (cytoplasmic side of ER membrane) is
therefore the most precise CC.
In some cancers KDSR clears the toxic intermediate 3KDS; KDSR loss causes 3KDS accumulation,
ER dysfunction and proteotoxic stress -> potential therapy target [PMID:36170811 (full text cached)].
id: Q06136
gene_symbol: KDSR
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: KDSR (3-ketodihydrosphingosine reductase; also known as FVT-1 and SDR35C1)
is an NADPH-dependent short-chain dehydrogenase/reductase that catalyses the second
step of de novo sphingolipid biosynthesis, the reduction of 3-ketodihydrosphingosine
(3-ketosphinganine / 3-oxosphinganine) to dihydrosphingosine (sphinganine). This
step follows the serine palmitoyltransferase (SPT)-catalysed condensation of L-serine
and palmitoyl-CoA and precedes N-acylation by the ceramide synthases, feeding the
downstream production of ceramide and complex sphingolipids. It is the principal
KDS reductase in mammalian cells and is essential for flux through this pathway.
The enzyme is a multi-pass endoplasmic reticulum membrane protein whose large catalytic
domain, carrying the NADPH-binding site and active-site residues, faces the cytosolic
side of the ER membrane. Loss-of-function mutations cause erythrokeratodermia variabilis
et progressiva 4 (a recessive skin/keratinization disorder) and a spectrum of keratinization
disorders that can be accompanied by thrombocytopenia due to impaired proplatelet
formation.
alternative_products:
- name: '1'
id: Q06136-1
- name: '2'
id: Q06136-2
sequence_note: VSP_056641
existing_annotations:
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: Phylogenetic (IBA) inference that KDSR is active in the ER membrane. This
is strongly supported by direct experimental evidence in human and mouse.
action: ACCEPT
reason: KDSR is an integral ER membrane protein with its catalytic domain on the
cytosolic face of the ER; the IBA localization is correct and at an appropriate
level of specificity.
supported_by:
- reference_id: PMID:15328338
supporting_text: hFVT-1 is localized at the endoplasmic reticulum
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Endoplasmic reticulum membrane'
- term:
id: GO:0030148
label: sphingolipid biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetic (IBA) inference that KDSR is involved in sphingolipid biosynthesis.
This is the core biological process of the gene.
action: ACCEPT
reason: KDSR catalyses the second, obligatory step of de novo sphingolipid biosynthesis;
this is directly supported by experimental and mutation data in addition to
the phylogenetic inference.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: the second step of de novo sphingolipid biosynthesis
- reference_id: PMID:19141869
supporting_text: FVT1 is the principal 3-ketosphinganine reductase in mammalian
cells
- term:
id: GO:0006666
label: 3-keto-sphinganine metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetic (IBA) inference that KDSR participates in 3-keto-sphinganine
metabolism. KDSR consumes 3-keto-sphinganine (3-ketodihydrosphingosine), its
direct substrate.
action: ACCEPT
reason: 3-keto-sphinganine (3-oxosphinganine) is the direct substrate of KDSR;
this is a precise, correct BP for the enzyme's substrate metabolism, complementing
the broader sphingolipid biosynthetic process term.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH +
H(+)
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Phylogenetic (IBA) inference of 3-dehydrosphinganine reductase (KDS reductase)
activity. This is the defining molecular function of KDSR.
action: ACCEPT
reason: This IBA annotation captures the core molecular function of KDSR and is
concordant with direct enzymatic characterization of the purified human protein.
supported_by:
- reference_id: PMID:15328338
supporting_text: exhibited NADPH-dependent KDS reductase activity
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Electronic annotation of ER membrane localization from the UniProt Subcellular
Location mapping, consistent with experimental evidence.
action: ACCEPT
reason: The ER membrane localization is experimentally established; this IEA is
accurate.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Endoplasmic reticulum membrane'
- term:
id: GO:0006666
label: 3-keto-sphinganine metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: InterPro2GO electronic annotation to 3-keto-sphinganine metabolic process
based on the KDSR-like family signature (IPR045022).
action: ACCEPT
reason: The InterPro family assignment correctly maps to the substrate-metabolism
BP; consistent with the enzyme's characterized reaction.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH +
H(+)
- term:
id: GO:0030148
label: sphingolipid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Electronic annotation (combined IEA methods / ARBA) to sphingolipid biosynthetic
process, the core BP of KDSR.
action: ACCEPT
reason: Correct core biological process, redundant with better-supported experimental
annotations to the same term.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: the second step of de novo sphingolipid biosynthesis
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Electronic annotation of the reductase molecular function from InterPro/RHEA/EC
mappings (EC 1.1.1.102, RHEA:22640).
action: ACCEPT
reason: Correctly assigns the defining molecular function via the enzyme's EC number
and Rhea reaction; concordant with experimental data.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: EC=1.1.1.102
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: Bare "protein binding" from a large-scale yeast two-hybrid interactome
study, capturing interactions with KIF1B, HSPB1, TTR and WFS1. This term is
uninformative about KDSR's molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: The GO:0005515 "protein binding" term conveys no specific functional information,
and the underlying interactions are high-throughput Y2H hits from a neurodegeneration
interactome screen with no established relevance to KDSR's enzymatic role. Per
curation guidance, bare protein binding is retained but flagged as an over-annotation
rather than removed.
supported_by:
- reference_id: PMID:32814053
supporting_text: systematic yeast two-hybrid interaction screening
- term:
id: GO:0030148
label: sphingolipid biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1660661
qualifier: involved_in
review:
summary: Reactome traceable annotation placing KDSR in de novo sphingolipid biosynthesis.
action: ACCEPT
reason: Reactome correctly assigns KDSR to the sphingolipid de novo biosynthesis
pathway; this is the core BP.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: the second step of de novo sphingolipid biosynthesis
- term:
id: GO:0006665
label: sphingolipid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: UniPathway-based electronic annotation to the broad sphingolipid metabolic
process term.
action: KEEP_AS_NON_CORE
reason: Correct but less informative than the biosynthetic-process child term (GO:0030148),
which is separately annotated with experimental support. Retained as a valid
but general parent annotation.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: 'PATHWAY: Lipid metabolism; sphingolipid metabolism'
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-428123
qualifier: enables
review:
summary: Reactome traceable annotation of the KDS reductase molecular function
(reaction "KDSR reduces 3-ketosphingoid").
action: ACCEPT
reason: Correctly captures the defining molecular function of KDSR.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH +
H(+)
- term:
id: GO:0046513
label: ceramide biosynthetic process
evidence_type: IDA
original_reference_id: PMID:1317856
qualifier: involved_in
review:
summary: Classic biochemical study localizing serine palmitoyltransferase, 3-dehydrosphinganine
reductase and sphinganine N-acyltransferase to the cytosolic face of mouse liver
ER. The reductase activity feeds the pathway that produces dihydroceramide/ceramide.
action: KEEP_AS_NON_CORE
reason: KDSR (3-dehydrosphinganine reductase) provides sphinganine, an obligatory
precursor for ceramide synthesis, and this paper measures the reductase activity
as part of the early ceramide-forming pathway. However, KDSR does not itself
catalyse ceramide formation, so ceramide biosynthetic process is a pathway-level
annotation kept as non-core rather than a direct catalytic function.
supported_by:
- reference_id: PMID:1317856
supporting_text: are responsible for the first steps in sphingolipid
- reference_id: PMID:1317856
supporting_text: '3-oxosphinganine, sphinganine, and dihydroceramide'
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: IDA
original_reference_id: PMID:36170811
qualifier: enables
review:
summary: Study establishing that KDSR reduces 3KDS to sphinganine and that KDSR
loss causes toxic 3KDS accumulation. Supports the reductase molecular function.
action: ACCEPT
reason: Directly attributes the 3KDS-reducing (3-dehydrosphinganine reductase)
activity to KDSR; this is the core molecular function.
supported_by:
- reference_id: PMID:36170811
supporting_text: 3KDS is subsequently converted to sphinganine by 3KDS reductase
(KDSR)
- term:
id: GO:0006686
label: sphingomyelin biosynthetic process
evidence_type: IDA
original_reference_id: PMID:36170811
qualifier: involved_in
review:
summary: KDSR loss affects downstream sphingomyelin levels because sphingomyelin
is a major downstream product of de novo sphingolipid biosynthesis; sphingomyelins
were measured as downstream readouts of the KDSR-dependent pathway.
action: MARK_AS_OVER_ANNOTATED
reason: KDSR contributes to sphingomyelin biosynthesis only indirectly, by supplying
the sphinganine backbone upstream; it does not catalyse any sphingomyelin-forming
step. In this study cancer cells could still salvage sphingomyelin, and total
sphingomyelins did not necessarily decrease on KDSR knockout. This is a distal
pathway-product annotation rather than a direct function.
supported_by:
- reference_id: PMID:36170811
supporting_text: major downstream products of sphingolipid biosynthesis
- term:
id: GO:0006688
label: glycosphingolipid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:34080016
qualifier: involved_in
review:
summary: Reference is a review of glucosylceramide and galactosylceramide biology.
Glycosphingolipids are distal products of the de novo pathway that KDSR feeds,
but the reference does not itself assay or even mention KDSR.
action: MARK_AS_OVER_ANNOTATED
reason: Glycosphingolipid biosynthesis is several enzymatic steps downstream of
KDSR (sphinganine -> ceramide -> glucosyl/galactosylceramide -> complex GSL);
KDSR catalyses none of these glycosylation steps. The cited review never mentions
KDSR, so this is a pathway-level over-annotation, not a direct function.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: the second step of de novo sphingolipid biosynthesis
- term:
id: GO:0046513
label: ceramide biosynthetic process
evidence_type: IDA
original_reference_id: PMID:16120614
qualifier: involved_in
review:
summary: Study of the Serinc protein family, which forms an intracellular complex
with enzymes of serine and sphingolipid biosynthesis to incorporate serine into
membrane lipids. The abstract does not directly assay KDSR in ceramide synthesis.
action: KEEP_AS_NON_CORE
reason: Ceramide biosynthesis is downstream of the sphinganine KDSR produces; KDSR
is required for the pathway but does not catalyse a ceramide-forming step. Because
only the abstract is available and the experimental (IDA) full text may implicate
KDSR in the biosynthetic complex, the annotation is retained as a valid pathway-level,
non-core assignment rather than removed.
supported_by:
- reference_id: PMID:16120614
supporting_text: enzymes involved in serine and sphingolipid biosyntheses
- term:
id: GO:0098554
label: cytoplasmic side of endoplasmic reticulum membrane
evidence_type: IDA
original_reference_id: PMID:19416851
qualifier: is_active_in
review:
summary: Annotation that KDSR is active on the cytoplasmic side of the ER membrane.
This is the most precise localization consistent with the enzyme's topology.
action: ACCEPT
reason: KDSR's large catalytic domain, bearing the active-site and NADPH-binding
residues, faces the cytosol at the ER membrane; the cytoplasmic-side term is
the most accurate CC and reflects where catalysis occurs.
supported_by:
- reference_id: PMID:15328338
supporting_text: which contains putative active site residues, faces the cytosol
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: TOPO_DOM 26..270
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:15328338
qualifier: located_in
review:
summary: Direct experimental (immunofluorescence) demonstration that human FVT-1/KDSR
localizes to the endoplasmic reticulum.
action: ACCEPT
reason: Robust experimental support for ER membrane localization.
supported_by:
- reference_id: PMID:15328338
supporting_text: hFVT-1 is localized at the endoplasmic reticulum
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:19141869
qualifier: located_in
review:
summary: Experimental localization and topology study placing FVT1/KDSR at the
ER membrane.
action: ACCEPT
reason: Confirms ER membrane localization by independent experimental methods.
supported_by:
- reference_id: PMID:19141869
supporting_text: oriented to place
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: EXP
original_reference_id: PMID:15328338
qualifier: enables
review:
summary: Purified recombinant human FVT-1/KDSR exhibits NADPH-dependent KDS reductase
activity in vitro, and rescues KDS reductase-deficient yeast.
action: ACCEPT
reason: Direct enzymatic demonstration of the defining molecular function; core
function.
supported_by:
- reference_id: PMID:15328338
supporting_text: exhibited NADPH-dependent KDS reductase activity
- term:
id: GO:0006666
label: 3-keto-sphinganine metabolic process
evidence_type: IMP
original_reference_id: PMID:19141869
qualifier: involved_in
review:
summary: Silencing/mutation of FVT1 alters 3-ketosphinganine reductase activity,
implicating KDSR in 3-keto-sphinganine metabolism.
action: ACCEPT
reason: Loss-of-function evidence supports KDSR's role in metabolizing its substrate
3-keto-sphinganine.
supported_by:
- reference_id: PMID:19141869
supporting_text: FVT1 is the principal 3-ketosphinganine reductase in mammalian
cells
- term:
id: GO:0030148
label: sphingolipid biosynthetic process
evidence_type: IMP
original_reference_id: PMID:19141869
qualifier: involved_in
review:
summary: Mutational/silencing evidence that FVT1/KDSR is required for long-chain
base (sphingoid) synthesis, i.e. sphingolipid biosynthesis.
action: ACCEPT
reason: Core biological process supported by loss-of-function data.
supported_by:
- reference_id: PMID:19141869
supporting_text: required for long-chain base synthesis in yeast and mammals
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: IMP
original_reference_id: PMID:19141869
qualifier: enables
review:
summary: FVT1 silencing directly correlates with cellular KDS reductase activity,
identifying KDSR as the principal enzyme carrying this activity.
action: ACCEPT
reason: Loss-of-function evidence for the defining molecular function; core function.
supported_by:
- reference_id: PMID:19141869
supporting_text: a direct correlation between FVT1 levels and reductase activity
- term:
id: GO:0030148
label: sphingolipid biosynthetic process
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: Sequence-similarity-based transfer of sphingolipid biosynthetic process
from the yeast ortholog (TSC10, P38342).
action: ACCEPT
reason: Correct core BP; the ortholog-based inference agrees with direct experimental
data in human.
supported_by:
- reference_id: PMID:19141869
supporting_text: required for long-chain base synthesis in yeast and mammals
- term:
id: GO:0070402
label: NADPH binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: Sequence-similarity inference of NADPH binding, consistent with the Rossmann-fold
NADPH-binding motif and the NADPH-dependent reductase mechanism.
action: ACCEPT
reason: KDSR is an NADPH-dependent reductase with a conserved N-terminal NADPH-binding
(Rossmann) region; NADPH binding is a genuine molecular function supporting the
catalytic activity.
supported_by:
- reference_id: PMID:15328338
supporting_text: exhibited NADPH-dependent KDS reductase activity
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: /ligand="NADPH"
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: IMP
original_reference_id: PMID:28575652
qualifier: enables
review:
summary: Disease-gene study showing biallelic KDSR mutations cause progressive
symmetric erythrokeratoderma, with yeast complementation and immunohistochemistry
demonstrating defective KDSR function.
action: ACCEPT
reason: Patient mutations that abolish/impair the reductase function, validated
by yeast complementation, provide loss-of-function support for the enzymatic
activity.
supported_by:
- reference_id: PMID:28575652
supporting_text: demonstrated that the mutations cause defects in KDSR function
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: High-throughput proteomics identification of KDSR in the membrane proteome
of an NK-like cell line.
action: KEEP_AS_NON_CORE
reason: Correct but very general; KDSR is an integral membrane protein, and the
more specific ER membrane / cytoplasmic side of ER membrane annotations are the
informative localizations. Retained as a non-core, low-specificity localization.
supported_by:
- reference_id: PMID:19946888
supporting_text: define the composition of the membrane
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-428123
qualifier: located_in
review:
summary: Reactome traceable annotation of ER membrane localization.
action: ACCEPT
reason: Consistent with the experimentally established ER membrane localization.
supported_by:
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Endoplasmic reticulum membrane'
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IDA
original_reference_id: PMID:15364918
qualifier: located_in
review:
summary: MGI-assigned IDA to endoplasmic reticulum. The cited reference (PMID:15364918)
is a study of IP3R1 lateral diffusion in neurons and does not concern KDSR, so
this appears to be a mis-attributed citation; however ER localization of KDSR
is itself well established.
action: ACCEPT
reason: The endoplasmic reticulum localization is correct and independently supported
by direct experimental evidence (PMID:15328338, PMID:19141869). The original
reference appears to be a wrong-PMID citation (flagged in reference_review),
but the annotation content is accurate and is retained on the basis of the other
evidence.
supported_by:
- reference_id: PMID:15328338
supporting_text: hFVT-1 is localized at the endoplasmic reticulum
- term:
id: GO:0006666
label: 3-keto-sphinganine metabolic process
evidence_type: IDA
original_reference_id: PMID:15364918
qualifier: acts_upstream_of_or_within
review:
summary: MGI-assigned IDA linking KDSR to 3-keto-sphinganine metabolism. The cited
reference is an IP3R1 diffusion study unrelated to KDSR, so the citation appears
mis-attributed, but the underlying biology (KDSR metabolizes 3-keto-sphinganine)
is correct.
action: ACCEPT
reason: KDSR reduces 3-keto-sphinganine (its substrate); the BP is correct and
well supported by direct enzymology elsewhere. The original PMID is flagged as
a likely wrong-identifier citation but does not affect the correctness of the
annotation.
supported_by:
- reference_id: PMID:19141869
supporting_text: FVT1 is the principal 3-ketosphinganine reductase in mammalian
cells
- term:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
evidence_type: IDA
original_reference_id: PMID:15364918
qualifier: enables
review:
summary: MGI-assigned IDA to the reductase molecular function. The cited reference
is an IP3R1 lateral-diffusion study unrelated to KDSR, so the citation is likely
mis-attributed; nonetheless the reductase activity is the well-established core
function of KDSR.
action: ACCEPT
reason: The 3-dehydrosphinganine reductase activity is the defining, extensively
validated molecular function of KDSR. The original PMID appears to be a wrong-identifier
citation (flagged in reference_review), but the annotation itself is correct
and supported by direct enzymology (PMID:15328338, PMID:19141869).
supported_by:
- reference_id: PMID:15328338
supporting_text: exhibited NADPH-dependent KDS reductase activity
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: PMID:8417785
qualifier: located_in
review:
summary: Legacy annotation (ProtInc) derived from the 1993 FVT-1 cloning paper,
which described FVT-1 as a "putatively secreted protein" based on sequence prediction
before its function was known.
action: REMOVE
reason: This localization is contradicted by all subsequent experimental evidence
KDSR is a multi-pass integral endoplasmic reticulum membrane protein with its
catalytic domain facing the cytosol, not a secreted/extracellular protein. The
extracellular assignment reflects an outdated sequence-based prediction of secretion
that has been superseded, and is a demonstrably wrong legacy inference.
supported_by:
- reference_id: PMID:8417785
supporting_text: codes for a putatively secreted protein of 36 Kd
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: Multi-pass
core_functions:
- description: NADPH-dependent 3-ketodihydrosphingosine (3-dehydrosphinganine) reductase
that catalyses the second step of de novo sphingolipid biosynthesis, reducing
3-ketodihydrosphingosine to dihydrosphingosine (sphinganine) at the cytosolic
face of the ER membrane.
molecular_function:
id: GO:0047560
label: 3-dehydrosphinganine reductase activity
supported_by:
- reference_id: PMID:15328338
supporting_text: exhibited NADPH-dependent KDS reductase activity
- reference_id: file:human/KDSR/KDSR-uniprot.txt
supporting_text: 'Reaction=sphinganine + NADP(+) = 3-oxosphinganine + NADPH + H(+)'
directly_involved_in:
- id: GO:0030148
label: sphingolipid biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:1317856
title: Subcellular localization and membrane topology of serine palmitoyltransferase,
3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Primary biochemical study localizing 3-dehydrosphinganine reductase
(KDSR) activity to the cytosolic face of mouse liver ER; supports the reductase
function and ER cytosolic-side topology.
- id: PMID:15328338
title: FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site
that faces the cytosolic side of the endoplasmic reticulum membrane.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Key paper identifying human FVT-1/KDSR as the mammalian KDS reductase;
purified enzyme has NADPH-dependent activity, localizes to ER, catalytic domain
faces cytosol.
- id: PMID:15364918
title: Lateral diffusion of inositol 1,4,5-trisphosphate receptor type 1 is regulated
by actin filaments and 4.1N in neuronal dendrites.
findings: []
reference_review:
relevance: NONE
correctness: WRONG_IDENTIFIER
review_notes: This PMID is a study of IP3R1 lateral diffusion in neurons and does
not concern KDSR, yet it is cited as the MGI IDA source for three KDSR annotations
(ER localization, 3-keto-sphinganine metabolic process, and reductase activity).
Appears to be a wrong-PMID/mis-attributed citation. The affected annotations
are nonetheless biologically correct and are independently supported by PMID:15328338
and PMID:19141869.
- id: PMID:16120614
title: Serinc, an activity-regulated protein family, incorporates serine into membrane
lipid synthesis.
findings: []
reference_review:
relevance: LOW
correctness: UNVERIFIED
review_notes: Study of the Serinc family that forms complexes with serine/sphingolipid
biosynthetic enzymes; abstract only, does not directly assay KDSR in ceramide
synthesis. Used to support a pathway-level ceramide biosynthesis annotation.
- id: PMID:19141869
title: 'Tsc10p and FVT1: topologically distinct short-chain reductases required
for long-chain base synthesis in yeast and mammals.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Establishes FVT1/KDSR as the principal mammalian 3-ketosphinganine
reductase required for long-chain base (sphingoid) synthesis; provides silencing,
mutagenesis, localization and topology data.
- id: PMID:19416851
title: Identification of small subunits of mammalian serine palmitoyltransferase
that confer distinct acyl-CoA substrate specificities.
findings: []
reference_review:
relevance: MEDIUM
correctness: UNVERIFIED
review_notes: Abstract focuses on SPT small subunits; cited as the IDA source for
KDSR being active on the cytoplasmic side of the ER membrane. Only the abstract
is available; the cytosolic-face topology of KDSR is independently well established.
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: High-throughput membrane proteomics; supports only the general "membrane"
localization of KDSR.
- id: PMID:28575652
title: Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Disease-gene identification; biallelic KDSR mutations cause progressive
symmetric erythrokeratoderma, with yeast complementation showing loss of KDSR
function.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Large-scale yeast two-hybrid interactome; source of four uninformative
protein-binding interactions for KDSR (KIF1B, HSPB1, TTR, WFS1). No established
functional relevance to KDSR's enzymatic role.
- id: PMID:34080016
title: Glucosylceramide and galactosylceramide, small glycosphingolipids with significant
impact on health and disease.
findings: []
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: Review of glucosyl-/galactosylceramide biology; does not mention
or assay KDSR. Cited for a glycosphingolipid biosynthesis annotation that is
several enzymatic steps downstream of KDSR - a pathway-level over-annotation.
- id: PMID:36170811
title: De novo sphingolipid biosynthesis necessitates detoxification in cancer cells.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Full text available; shows KDSR reduces 3KDS to sphinganine and that
KDSR loss causes toxic 3KDS accumulation, ER dysfunction and proteotoxic stress,
highlighting KDSR as a cancer therapy target.
- id: PMID:8417785
title: FVT-1, a novel human transcription unit affected by variant translocation
t(2;18)(p11;q21) of follicular lymphoma.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Original FVT-1 cloning paper describing the follicular-lymphoma translocation
and predicting a "putatively secreted protein"; the secretion prediction (basis
of the extracellular-region annotation) was later superseded by ER membrane topology.
- id: Reactome:R-HSA-1660661
title: Sphingolipid de novo biosynthesis
findings: []
- id: Reactome:R-HSA-428123
title: KDSR reduces 3-ketosphingoid
findings: []
- id: file:human/KDSR/KDSR-uniprot.txt
title: UniProtKB entry Q06136 (KDSR_HUMAN)
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: UniProt record for human KDSR; source of catalytic activity (EC 1.1.1.102,
RHEA:22640), ER membrane multi-pass topology, NADPH-binding sites, and disease
associations.